Skip to Content
WASHINGTON, DC — U.S. Representatives Pramila Jayapal (WA-07), Chris Deluzio (PA-17), Pat Ryan (NY-18), and Angie Craig (MN-02) are today launching the Monopoly Busters Caucus, a new caucus with nine Founding Members to fight corporate greed and promote a pro-worker,…
Issues:
Science, Technology, & Antitrust
SEATTLE, WA — U.S. Representative Pramila Jayapal (WA-07) issued the following statement regarding Donald Trump’s attempted chaotic, cruel, and unconstitutional federal funding freeze, which was temporarily stayed by a federal judge:
“Donald Trump’s latest stunt steals vast amounts of Congressionally…
Issues:
Arts & Education,
Environment,
Foreign Affairs & National Security,
Government Reform & Ethics,
Health Care,
Housing, Transportation, & Infrastructure,
Jobs, Labor, & the Economy,
Public Safety & Criminal Justice,
Science, Technology, & Antitrust
SEATTLE, WA – U.S. Representative Pramila Jayapal (WA-07) released the following statement following the Department of Justice’s (DOJ) filing of proposed remedies, including a potential breakup of the company to address their monopolistic practices:
“I applaud the Biden-Harris Administration and…
Issues:
Science, Technology, & Antitrust
SEATTLE – U.S. Representative Pramila Jayapal (WA-07) is today announcing her Community Project Funding (CPF) requests that she will be advocating to include in the Fiscal Year 2025 (FY25) appropriations bills. These 15 projects could bring up to $56 million…
Issues:
Arts & Education,
Environment,
Housing, Transportation, & Infrastructure,
Jobs, Labor, & the Economy,
Science, Technology, & Antitrust
WASHINGTON – U.S. Representative Pramila Jayapal (WA-07) released the following statement regarding her vote against H.R. 7521, the Protecting Americans from Foreign Adversary Controlled Applications Act. The legislation today passed the House by a vote of 352-65.
“I voted no…
Issues:
Foreign Affairs & National Security,
Science, Technology, & Antitrust
Warren, Jayapal Announce Three Drug Manufacturers Pulled Sham Patents after Warnings, Urge FDA to Continue Fight Against Big Pharma Companies’ Patent Abuse
Lawmakers Probed Big Pharma’s Sham Patent Claims after FTC Warnings in December 2023; Are Now Sharing Responses with…
Issues:
Health Care,
Science, Technology, & Antitrust
